Express Scripts Sees Rapid Switching to Zocor
This article was originally published in The Pink Sheet Daily
Executive Summary
The success at switching patients to Zocor ahead of the availability of a generic demonstrates the success of PBMs in driving market share, CEO Paz says.
You may also be interested in...
Lipitor Sales Plummet 13 Percent In Q2 On Inventory Fluctuations, Generic Pressure
Pfizer also reports 48 percent drop in earnings due to patent losses, upfront payment to Bristol for anticoagulant apixaban deal.
Lipitor Sales Plummet 13 Percent In Q2 On Inventory Fluctuations, Generic Pressure
Pfizer also reports 48 percent drop in earnings due to patent losses, upfront payment to Bristol for anticoagulant apixaban deal.
Express Scripts CEO Sees Transparency Law Consequences
PBMs are able to secure better prices from manufacturers without transparency, Paz says.